Position in AXSM
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$14,435,555
-$1,002,562 QoQ
Shares Held
58,976
-35.4% QoQ
Ownership
0.113%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#106
of 503 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AXSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026M&G PLC holds $116,189,172 across 10 Biotechnology names. AXSM ranks #2 (12.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
223,445 | $63,675,121 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
This page
|
58,976 | $14,435,555 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
216,096 | $12,365,013 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
35,912 | $10,810,589 | |
| 5 | INSM |
INSMED Inc
|
88,008 | $9,383,412 | |
| 6 | BRNS |
Barinthus Biotherapeutics plc.
|
5,197,349 | $3,430,250 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
4,296 | $804,554 | |
| 8 | MESO |
Mesoblast Ltd
|
59,100 | $799,623 |
All Filings in AXSM
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,435,555 | 58,976 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $15,438,117 | 91,339 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $16,497,505 | 90,328 | Shares | Defined | 2026-02-12 | |
| No filing history on record for this holder in this stock. | ||||||